Perrigo Company plc Debt Instrument, Fair Value Disclosure
Perrigo Company plc (PRGO) had Debt Instrument, Fair Value Disclosure of $890.90 million as of 2015-09-26, per its 10-Q filed 2015-11-02.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2015-11-02
- 2015-09-26: Debt Instrument, Fair Value Disclosure $890.90M.
- 2015-06-27: Debt Instrument, Fair Value Disclosure $902.40M.
- 2014-06-28: Debt Instrument, Fair Value Disclosure $900.00M; Debt Instrument, Fair Value Disclosure as first filed $2.40B.
- 2013-06-29: Debt Instrument, Fair Value Disclosure $1.50B.
| Period end | Debt Instrument, Fair Value Disclosure | Debt Instrument, Fair Value Disclosure as first filed |
|---|---|---|
| 2015-09-26 | $890.90M 10-Q · filed 2015-11-02 | |
| 2015-06-27 | $902.40M 10-Q · filed 2015-11-02 | |
| 2014-06-28 | $900.00M 10-K · filed 2015-08-13 | $2.40B 10-K · filed 2014-08-14 |
| 2013-06-29 | $1.50B 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |